A--Drug Manufacturing and Formulation Program (DMFP)
National Institutes of Health · NATIONAL INSTITUTES OF HEALTH NIDA
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 75N95024R00077 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Note the winner and the end of the period of performance for the recompete.
- Follow the agency to see the next notice for this work.
What the notice says
Four (4) Indefinite Delivery/Indefinite Quantity (IDIQ) type contracts with a maximum ordering value of $49,999,999.00 and an ordering period from May 4, 2026 through May 3, 2036, were awarded on May 4, 2026. Concurrently, the first task orders were issued to each awardee with an effective date of May 4, 2026 through July 3, 2026, in the firm-fixed price amount totaling $5,000.00.
Who won similar work
4 award notices on SAM.gov in the last 24 months. Match: Same agency (National Institutes of Health), same NAICS 325412.
| Winner | Awards | Value | Last |
|---|---|---|---|
| EMINENT SERVICES CORP | 1 | – + 1 shared | Jul 8, 2026 |
| KYMANOX CORP | 1 | – + 1 shared | Jul 8, 2026 |
| MURTY PHARMACEUTICALS, INC. | 1 | – + 1 shared | Jul 8, 2026 |
| SRI INTERNATIONAL Menlo Park CA 94025 USA | 1 | – + 1 shared | Jul 8, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.
- Jul 8, 2026EMINENT SERVICES CORP$49.9M (shared ceiling)Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
- Jul 8, 2026KYMANOX CORP$49.9M (shared ceiling)Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
- Jul 8, 2026MURTY PHARMACEUTICALS, INC.$49.9M (shared ceiling)Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
- Jul 8, 2026SRI INTERNATIONAL Menlo Park CA 94025 USA$49.9M (shared ceiling)Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
Competitive landscape
For the 4 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Natl Institutes of Health (NIH) since 2024 (0 filings)
- 0 of their lobbyists list a past Natl Institutes of Health (NIH) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 0 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.